Table 3.
Characteristic | High IQ (N=34) | Normal IQ (N=276) | Low IQ (N=21) | P-value |
---|---|---|---|---|
Any treatment with stimulants, n (%) | 27 (79.4) | 207 (75.0) | 19 (90.5) | 0.25 |
No. of subjects with sufficient information regarding dates and dosages for stimulant treatment | 25 | 199 | 17 | |
Age at onset of treatment with stimulants (years) | 0.97 | |||
Mean (SD) | 10.3 (3.3) | 10.4 (3.4) | 10.2 (3.2) | |
Median | 9.6 | 9.9 | 9.4 | |
Range | (4.5–17.1) | (2.0–18.4) | (4.9–15.7) | |
Duration of treatment with stimulants (months) | 0.45 | |||
Mean (SD) | 46.3 (40.0) | 43.1 (37.5) | 33.2 (32.1) | |
Median | 36.7 | 35.9 | 24.6 | |
Range | (1.0–138.6) | (0.5–160.0) | (0.5–110.9) |